Fujisawa, T.; Joshi, B.H.; Takahashi, S.; Takasaki, Y.; Suzuki, A.; Ito, K.; Ochiai, K.; Tomishima, K.; Ishii, S.; Puri, R.K.;
et al. IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer. Diagnostics 2021, 11, 1140.
https://doi.org/10.3390/diagnostics11071140
AMA Style
Fujisawa T, Joshi BH, Takahashi S, Takasaki Y, Suzuki A, Ito K, Ochiai K, Tomishima K, Ishii S, Puri RK,
et al. IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer. Diagnostics. 2021; 11(7):1140.
https://doi.org/10.3390/diagnostics11071140
Chicago/Turabian Style
Fujisawa, Toshio, Bharat H. Joshi, Sho Takahashi, Yusuke Takasaki, Akinori Suzuki, Koichi Ito, Kazushige Ochiai, Ko Tomishima, Shigeto Ishii, Raj K. Puri,
and et al. 2021. "IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer" Diagnostics 11, no. 7: 1140.
https://doi.org/10.3390/diagnostics11071140
APA Style
Fujisawa, T., Joshi, B. H., Takahashi, S., Takasaki, Y., Suzuki, A., Ito, K., Ochiai, K., Tomishima, K., Ishii, S., Puri, R. K., & Isayama, H.
(2021). IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer. Diagnostics, 11(7), 1140.
https://doi.org/10.3390/diagnostics11071140
